ACR Hill Visits Yield Key Bill Support; Plus Medicare, Biosimilar Wins
ACR Leaders Discuss E/M Coding Changes, Step Therapy & More
4 Rheumatoid Arthritis Therapy Principles, & New Drug Info
ACR/ARHP Visits the Hill; Drug Pricing ‘Blueprint’ Revealed
Gap in Regulating Biotech Drug Copies Prompts WHO to Step In
AbbVie, Samsung Bioepis in Deal; Humira Biosimilar U.S. Release in 2023
The Science Behind Biosimilars
Ferumoxytol Injection Receives New Indication, & Application for GP2017 Moves Ahead
Should Patients with Rheumatic Disease Switch from Biologic to Biosimilar?
- 1
- 2
- 3
- …
- 7
- Next Page »